← Back to exam page

ASCP-MLT – MEDICAL LABORATORY TECHNICIAN - MLT(ASCP)

Loading demo links...

Showing 1–3 of 20 questions

Question 1

Match each of the following definitions associated with heart disease and heart failure to the term that it defines.

1. Congestive heart failure

2. Infarction

3. Ischemia

4. Angina

Select all that apply, then click Submit answer.

  • ○

    An inadequate blood supply that decreases availability of oxygen.
  • ○

    Chest pain caused by inadequate supply of oxygen to heart myocardium.
  • ○

    An area of tissue death that occurs due to lack of oxygen.
  • ○

    A left ventricular dysfunction resulting from aging, hypertension, atherosclerosis or muscle damage from an AMI or repeated AMIs.
Question 2

Measures Light scatter by particles - Nephelometer

Measures change in vapor pressure - Osmometer

Measures amount of electricity passing between two electrodes - Coulometry

Measures absorbance of light at a specific wavelength - Spectrophotometer

Lab operations

Matching

1. Measures Light scatter by particles

2. Measures change in vapor pressure

3. Measures amount of electricity passing between two electrodes

4. Measures absorbance of light at a specific wavelength

Select all that apply, then click Submit answer.

  • ○

    Coulometry
  • ○

    Nephelometer
  • ○

    Spectrophotometer
  • ○

    Osmometer
Question 3

Certain recipients have increased risk for developing TA-GVHD. They are:

Neonates less than 4 months of age

Fetuses

Recipients with a congenital or acquired immunodeficiency, such as bone marrow or stem cell recipients, and patients receiving chemotherapy

recipients of donor units from a blood relative

Which of the following patients are at risk for transfusion-associated graft versus host disease (TA-GVHD) and require irradiated cellular blood products? (Choose all that apply)

Select all that apply, then click Submit answer.

  • ○

    Neonates less than 4 months of age
  • ○

    Recipients of donor units known to be from a blood relative.
  • ○

    Patients with chronic anemias.
  • ○

    Patient receiving chemotherapy who are immunocompromised.
  • ○

    Patients with a history of allergic reactions.